Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,085 across all filing types
Latest filing 2020-07-06 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
关于部分限制性股票回购注销完成的公告
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from a company regarding the completion of a repurchase and cancellation of restricted shares. It details the number of shares repurchased, the price, the approval process, and the impact on the company's share capital structure. There is no financial statement or comprehensive financial report included, nor is it a report publication announcement. The content focuses on the company's buyback and cancellation of its own shares, which fits the category of 'Transaction in Own Shares'. The document length is 3823 characters, which is consistent with an announcement rather than a full report. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2020-07-06 Chinese
2020年第一次临时股东大会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legitimacy and procedures of a company's 2020 first extraordinary general meeting (临时股东大会). It details the convening, attendance, voting procedures, and results of the shareholders' meeting. The document does not contain financial statements or financial performance data, nor is it a report of financial results or management discussion. It is a legal opinion related to a shareholders' meeting, specifically focusing on the legality and validity of the meeting and voting process. This type of document is best classified under Regulatory Filings (RNS) as it is a compliance/legal document that does not fit into other specific categories such as AGM Information or Declaration of Voting Results, since it is a legal opinion rather than the meeting materials or voting results announcement itself. The document length is under 5,000 characters, and it is not an announcement of a report but a standalone legal opinion letter.
2020-06-18 Chinese
2020年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 2020 first extraordinary general meeting (临时股东大会) of the company 西藏易明西雅医药科技股份有限公司. It details the meeting notice, attendance, voting results, and legal opinions related to the meeting. There is no financial data or report content, only the voting results and procedural information. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (2244 characters) and it is clearly an announcement of voting results rather than a full report or presentation. Therefore, the correct classification is DVA with high confidence.
2020-06-18 Chinese
关于公司大股东部分股份质押展期的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding the extension of the pledge period for shares held by a major shareholder (周战) of the company 西藏易明西雅医药科技股份有限公司. It details the number of shares pledged, the pledge start and expiry dates, and confirms that this is an extension of an existing pledge, not a new financing arrangement. The document does not contain financial statements or detailed financial analysis, nor does it present a report or results. It is a regulatory disclosure about a shareholder's pledged shares and their extension. This fits the category of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership or related share pledging activities by major shareholders. The document length is short (1707 characters), and it is not an announcement of a report publication but a direct disclosure. Therefore, the appropriate classification is MRQ with high confidence.
2020-06-10 Chinese
简式权益变动报告书
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the changes in shareholding by a significant shareholder (西藏华金天马股权投资合伙企业) in the listed company 西藏易明西雅医药科技股份有限公司. The content includes specifics about shareholding before and after the change, methods of share reduction, dates, and legal compliance statements. It is a formal report on changes in major shareholding stakes, including disclosures required by securities laws and stock exchange regulations. There is no indication that this is an annual report, earnings release, or any other type of financial or management report. The document fits the definition of a Major Shareholding Notification, which involves notifying changes in significant share ownership levels crossing thresholds. The document length (7895 characters) and detailed content confirm it is the report itself, not just an announcement or certification. Therefore, the correct classification is Major Shareholding Notification (MRQ).
2020-06-03 Chinese
关于披露简式权益变动报告书的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a disclosure announcement regarding a simplified equity change report from a shareholder holding more than 5% of the company's shares. It details the reduction in shareholding by the shareholder, including dates, quantities, and prices of shares sold. The document references a '简式权益变动报告书' (Simplified Equity Change Report) and provides a summary of the shareholding changes before and after the transactions. It does not contain financial statements or detailed financial performance data but focuses on notifying the market about changes in major shareholding levels. This matches the definition of a Major Shareholding Notification (MRQ). The document length is short (1875 characters), and it is not an announcement of a report publication but the actual notification of shareholding changes.
2020-06-03 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.